Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Fuchs Henry J
Relationship:  
City:   Palo Alto
State:   CA
   
Insider Summary:
  
   
Companies Owned :   5    
Direct Shares   222,228    

Indirect Shares

   0      
Direct Value   $18,063,061    

Indirect Value

   $0      
Total Shares   222,228      
Total Value   $18,063,061      


Onyx Pharmaceuticals Inc $0 Biomarin Pharmaceutical Inc $17,448,765 Mirati Therapeutics, Inc. $614,296 Onyx Pharmaceuticals Inc $0 Biomarin Pharmaceutical Inc $17,448,765 Mirati Therapeutics, Inc. $614,296
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Onyx Pharmaceuticals Inc ONXX EVP & Chief Medical Of... 2008-11-18 14,891 2006-05-15 0    Premium*  
            Ardea Biosciences Inc RDEA Director 2012-06-19 0 2007-12-05 0    Premium*  
            Biomarin Pharmaceutical Inc BMRN President, Worldwide R&D 2024-03-15 196,872 2009-03-02 0    Premium*  
            Genomic Health Inc GHDX Director 2019-11-08 0 2014-04-01 0    Premium*  
            Mirati Therapeutics, Inc. MRTX 2023-01-20 10,465 2020-01-03 0    Premium*  
* Premium Members only  

Records found :    25         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 1
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2024-02-27 4 A $0.00 $0 D/D 53,204 247,458 0 -
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2024-03-15 4 A $0.00 $0 D/D 18,240 230,357 0 -
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2020-07-20 4 OE $63.10 $8,337,656 D/D 126,389 229,384 0 -
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2023-03-15 4 A $0.00 $0 D/D 16,840 228,986 0 -
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2023-03-15 4 D $87.74 $421,064 D/D (4,799) 224,187 0 -
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2023-02-28 4 A $0.00 $0 D/D 68,052 212,146 0 -
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2024-03-05 4 S $85.18 $3,010,396 D/D (35,341) 212,117 0 -
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2024-03-15 4 D $83.87 $2,808,387 D/D (33,485) 196,872 0 -
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2023-12-01 4 A $0.00 $0 D/D 17,750 194,254 0 -
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2023-03-16 4 D $93.41 $3,362,760 D/D (36,000) 188,187 0 -
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2023-04-28 4 A $66.88 $21,200 D/D 317 176,504 0 -
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2023-08-10 4 S $90.43 $1,085,111 D/D (12,000) 176,187 0 -
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2018-06-14 4 OE $21.51 $1,067,380 D/D 31,000 175,848 0 -
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2018-04-02 4 OE $26.49 $337,851 D/D 10,000 163,326 0 -
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2018-03-15 4 A $0.00 $0 D/D 16,040 162,488 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Medical Officer   •       –      –    2016-02-24 4 A $0.00 $0 D/D 87,537 160,383 0 -
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2022-03-15 4 A $0.00 $0 D/D 38,790 158,113 0 -
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2018-04-30 4 A $68.78 $21,254 D/D 309 157,101 0 -
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2018-03-22 4 D $81.36 $472,864 D/D (5,812) 156,676 0 -
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2018-04-02 4 AS $80.12 $801,200 D/D (10,000) 156,676 0 -
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2018-03-22 4/A D $81.36 $474,736 D/D (5,835) 156,653 0 -
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2018-06-04 4 D $92.07 $178,063 D/D (1,934) 155,167 0 -
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2018-06-14 4 AS $90.00 $2,790,085 D/D (31,000) 155,167 0 -
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2018-02-26 4/A A $0.00 $0 D/D 20,463 154,024 0 -
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2018-02-26 4 A $0.00 $0 D/D 20,324 153,885 0 -
  25  Records found
  1     
  Page 1 of 1  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us